Underscoring a need to control the rising cost of medicines, the Irish government is holding talks with four other small European nations about joining their coalition that negotiates with drug makers.

In a statement, Ireland’s health minister, Simon Harris, noted that he had sent a formal letter of intent to open negotiations with Belgium, the Netherlands, Luxembourg, and Austria to join their BeNeLuxA Initiative, which assesses the cost and benefits of medicines, and bargains over pricing.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy